The present invention is based on the isolation of genes responsible for the production of polytheonamide A and B. The so-derived genes could be transferred to easily culturable bacteria to produce the antitumor polypeptides in an ecologically sustainable manner and in theoretically unlimited amounts. Commercial Opportunities: Cancer ranks second in death worldwide and the patient pool for cancer therapies is rising in line with an aging global population. Therefore, the need for optimal therapies is very high.
firstname.lastname@example.org | TechnologieAllianz e.V.
New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.
Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.
22.05.2017 | Event News
17.05.2017 | Event News
16.05.2017 | Event News
22.05.2017 | Materials Sciences
22.05.2017 | Life Sciences
22.05.2017 | Physics and Astronomy